These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11078427)

  • 1. Plasma endothelin levels are unaltered by thyroid hormone status in humans.
    Lam HC; Lee JK; Lai KH; Chiang HT
    J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S382-5. PubMed ID: 11078427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased plasma levels of endothelin-1 in patients with hyperthyroidism.
    Letizia C; Centanni M; Cesareo R; De Ciocchis A; Cerci S; Scuro L; Fumarola A; D'Ambrosio C; Scavo D
    Metabolism; 1995 Oct; 44(10):1239-42. PubMed ID: 7476277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inactivation of thyrotrophin releasing hormone by plasma in thyroid disease.
    Jeffcoate SL; White N
    Clin Endocrinol (Oxf); 1975 May; 4(3):231-6. PubMed ID: 807439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma atriopeptin concentrations in hyperthyroidism, euthyroidism, and hypothyroidism: studies in man and rat.
    Ladenson PW; Langevin H; Michener M
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1172-6. PubMed ID: 2960689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radio-immunoassay of endothelin in human plasma.
    Sørensen SS
    Scand J Clin Lab Invest; 1991 Nov; 51(7):615-23. PubMed ID: 1810021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
    Akin F; Yaylali GF; Turgut S; Kaptanoglu B
    Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of thyroid status and paraventricular area lesions on the release of thyrotropin-releasing hormone and catecholamines into hypophysial portal blood.
    Rondeel JM; de Greef WJ; van der Schoot P; Karels B; Klootwijk W; Visser TJ
    Endocrinology; 1988 Jul; 123(1):523-7. PubMed ID: 3133200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual plasma ghrelin changes in the same patients in hyperthyroid, hypothyroid and euthyroid state.
    Ruchala M; Gurgul E; Stangierski A; Wrotkowska E; Moczko J
    Peptides; 2014 Jan; 51():31-4. PubMed ID: 24184592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST.
    Beck-Peccoz P; Roncoroni R; Mariotti S; Medri G; Marcocci C; Brabant G; Forloni F; Pinchera A; Faglia G
    J Clin Endocrinol Metab; 1990 Jul; 71(1):19-25. PubMed ID: 2370293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects.
    Erem C; Değer O; Bostan M; Orem A; Sönmez M; Ulusoy S; Telatar M
    Acta Cardiol; 1999 Apr; 54(2):77-81. PubMed ID: 10378018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of thyrotropin, prolactin, growth hormone, triiodothyronine and thyroxine after oral administration of thyrotropin releasing hormone in hypothyroid and hyperthyroid patients.
    Nedvídková J; Felt V
    Endokrinologie; 1976; 68(2):175-82. PubMed ID: 827434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between liver function tests and thyroid hormones in thyroid disorders.
    Ajala MO; Ogunro PS; Fasanmade OA
    Niger Postgrad Med J; 2013 Sep; 20(3):188-92. PubMed ID: 24287748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic polypeptide in atria and plasma in experimental hyperthyroidism and hypothyroidism.
    Kohno M; Takaori K; Matsuura T; Murakawa K; Kanayama Y; Takeda T
    Biochem Biophys Res Commun; 1986 Jan; 134(1):178-83. PubMed ID: 2936340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma immunoreactive endothelin in the acute and subacute phases of myocardial infarction in patients undergoing fibrinolysis.
    Lechleitner P; Genser N; Mair J; Maier J; Artner-Dworzak E; Dienstl F; Puschendorf B
    Clin Chem; 1993 Jun; 39(6):955-9. PubMed ID: 8504563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Thyroid Hormone Levels Within the Normal and/or Subclinical Hyper- or Hypothyroid Range Do Not Affect Circulating Irisin Levels in Humans.
    Panagiotou G; Pazaitou-Panayiotou K; Paschou SA; Komninou D; Kalogeris N; Vryonidou A; Mantzoros CS
    Thyroid; 2016 Aug; 26(8):1039-45. PubMed ID: 27267080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma immunoreactive endothelin-1 in experimental malignant hypertension.
    Kohno M; Murakawa K; Horio T; Yokokawa K; Yasunari K; Fukui T; Takeda T
    Hypertension; 1991 Jul; 18(1):93-100. PubMed ID: 1860718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets stimulate expression of endothelin mRNA and endothelin biosynthesis in cultured endothelial cells.
    Ohlstein EH; Storer BL; Butcher JA; Debouck C; Feuerstein G
    Circ Res; 1991 Sep; 69(3):832-41. PubMed ID: 1873876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant status in thyroid dysfunction.
    Resch U; Helsel G; Tatzber F; Sinzinger H
    Clin Chem Lab Med; 2002 Nov; 40(11):1132-4. PubMed ID: 12521231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma endothelin-1 levels are increased in atrial fibrillation patients with hyperthyroidism.
    Mayyas F; Saadeh N; Al-Muqbel K; Van Wagoner DR
    PLoS One; 2018; 13(12):e0208206. PubMed ID: 30513109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of thyroid status on plasma leptin levels in women.
    Ozata M; Ozisik G; Bingol N; Corakci A; Gundogan MA
    J Endocrinol Invest; 1998 Jun; 21(6):337-41. PubMed ID: 9699123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.